News for hackers. Stuff that matters.

siloed

Re:Everyone gets numbers wrong, even the New York Times on Tuesday April 19, 2022 @02:42PM (#31087163)
The Chicago bureau chief being off by 6% in a tweet is an example of "exceedingly, horrendously, tragically bad?" The story clearly says "because of Covid."

The tweet's claim is "...the statistic is misrepresented. The 13% number only captures people who worked from home BECAUSE OF CORONAVIRUS." That's exactly what it says in the story.

> Do you have examples of stories

Re:Everyone gets numbers wrong, even the New York Times on Tuesday April 19, 2022 @12:26PM (#31085338)
Agreed, this example goes against your narrative.

That's a huge claim to make without any evidence at all, interesting opinion I guess.

Re:Everyone gets numbers wrong, even the New York Times on Tuesday April 19, 2022 @12:06PM (#31085018)
Do you have examples of stories where the facts were "exceedingly, horrendously, tragically bad" and were published without any retraction?
Re:Everyone gets numbers wrong, even the New York Times on Tuesday April 19, 2022 @11:45AM (#31084702)
The NYT has an agenda to under-report the number of COVID infections?
Re:Eden on Wednesday April 13, 2022 @02:35PM (#31018449)
They are definitely not "it's [sic] most prestigious" market, but they inspire admiration among other devs
What? Do you mean SSRIs specifically? Or are you including SNRIs, α2 blockers, MAO inhibitors etc? Do you have any evidence to support this or just anecdotes?
The parent comment draws an important difference between the use of psychedelic therapy and, say, ECT. I support this research but "Big Psychiatry just wants the cash!" is a reddit-level of nuance we can do without please.
This is too broad a statement to support with evidence. This study was specifically about treatment-resistant chronic depression and the measured effects on the brain.
What's being described in the study is not self-reflection but serotonergic psychedelics' effects on the 5-HT2A receptors in the brain. For example, escitalopram (Lexapro) may help with self-reflection as well but this study was specifically studying patients with treatment-resistant depression.